Unicare Group: Enriching Lives With Innovative Healthcare Solutions

Alok Pandey, Founder & Director

Alok Pandey

Founder & Director

India’s Contract Development and Manufacturing Organization (CDMO) industry is growing exponentially, as the global demand for cost-efficiency in manufacturing practices and improvement of the ‘bottom line’ increase. The ability of Indian companies to offer a considerable cost efficiency advantage while maintaining high quality standards makes it a go-to choice of leading pharma companies across the world. Factors like the growth of the generics industry, demand for combating high healthcare product costs, search for minimizing drug procurement costs, and India’s pool of CDMO specialists and the largest number of USFDA approved plants outside of the US, are expected to further boost the rate of the industry’s growth.

However, customers often face challenges with finding a reliable and professionally managed progressive CDMO partner whose products are cost competitive and of a good quality with an attractive packaging, and who has a robust supply chain setup. Addressing these issues with exceptional manufacturing capabilities and a thriving network that fuels its supply chain functions is Unicare Healthsciences Pvt. Ltd. (UHPL)- a Thane-based CDMO renowned for delivering high-quality products in an expeditious manner.

Unique Care for All

Founded in 2010, UHPL, a part of the Unicare Group, stands as a rapidly growing and promising organization that was established with the aim of providing UNIQUE CARE to human life. With this purpose at its core, the company offers a big basket of products suited to meet the distinctive requirements of its diversified clientele. The company’s portfolio of products features finished formulations in pharmaceuticals, nutraceuticals, food supplements, and probiotics.

The Unicare Group, featuring UHPL (Unicare Healthsciences Pvt. Ltd.) and Uni LLP (Unicare Enterprises LLP) is a thriving group which is also actively engaged in PETCARE products under the umbrella of UNITAILZ brand, which is already listed & highly active on e-commerce platforms such as Amazon , Flipkart , Meesho etc and has some of the fastest growing brands in their respective segments of Cosmetics & Medicines.

UNICARE Group aspires to be a global company, manufacturing and marketing a range of quality products at competitive prices with attractive & innovative packaging while maintaining high degree of reliability & efficiency in our services

Alok Pandey, Founder & Director

This professionally managed Group is involved in contract manufacturing as well as marketing of a wide range of products in Domestic as well as International markets. The Group's product range has been designed to cater to the needs of diverse healthcare domains for human use as well as for PETs (Dogs, Cats, Birds, Small Pets). Unicare has established a global footprint, supplying its productsbrands across Asia and Africa including countries like the Philippines, Myanmar, Cambodia, Kenya, and French-West Africa. The firm already has strategic alliances & supply agreements in many markets of Asia, Africa & EU.

In this highly competitive domain, what sets the company apart is its commitment to provide quality products at competitive prices with attractive and innovative packaging. The company achieves this through a series of strategic initiatives such as maintaining low overheads and ensuring that it keeps highly efficient supply chain management & services. Furthermore, the company has forged strategic tie-ups and relationships in the industry with leading manufacturers across India that have robust manufacturing and R&D capabilities with manufacturing plants & systems that meet International GMP standards.

“What gives us leverage in this industry is our ability to respond quickly & satisfactorily to customers’ requirements.

Moreover, we believe our customers deserve only the best of experience with us, which is why our cost competitiveness, efficiency in regulatory filings, efficient and effective supply chain management, and our reliability & consistency of service help us build long term and enduring relationships in the markets. Also, we maintain a high degree of integrity and dependability as "long-term business can only thrive on trust”, shares Alok Pandey, Founder and Director, Unicare.

In addition to leveraging its robust network, the company also houses a dedicated quality team that engages in coordination on regular testing-approvals of products as per pre-agreed product specifications and standards. Through these practices, the company ensures that its solutions not just meet but surpass client expectations, placing it as a go-to partner for future business.

Milestones and Future Aspirations

Dedicated to delivering a stellar client experience every time, Unicare has consistently strived to stay ahead of industry trends and shape its solutions to fulfill the client needs. This dedication has resulted in the firm achieving a number of accolades and recognitions such as winning a number of international tenders including a huge tender from KEMSA (Kenya Medical Supplies Authority) for supplies of injectables for requirements of Government of Kenya, which it completed in record time. Unicare’s ability to stand up to the challenges and fulfill tenders successfully has allowed the company to thrive. While UHPL has some leading brands and presence in International markets, Uni LLP (UNITAILZ brand range) has been recognized & awarded for its ‘outstanding performance’ on Amazon Marketplace.

The Group aims to carry on in the coming years with equal zeal and advance towards becoming a globally renowned reckoning force in the industry. “We aspire to be a global company, manufacturing and marketing a range of quality products at competitive prices with attractive & innovative packaging while maintaining high degree of reliability & efficiency in our services. In UHPL, it is our mission to enhance the quality of human life by enabling people to do more, feel better and live longer and ultimately provide UNIQUE CARE to human life”, further adds Alok.

As the company moves ahead with its growth strategies, it is targeting MENA, UK, and EU markets for its next phase of growth. Penetrating these markets successfully will enable the firm to achieve an exceptional boost. Additionally, UHPL plans to enhance its product portfolio by adding Biologicals and Vaccines to it. Besides the growth of UHPL, the Group has plans for expansion of Uni LLP business across the Indian, UK and USA markets, in a bid to establish UNITAILZ brand for PETs in global markets.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.